The recent decision by the U.S. Drug Enforcement Administration (DEA) to shift cannabis to Schedule III is on its way to becoming reality. Read More
Analyst Articles
As overseas strife worsens, do you seek safe investment havens? Here are time-tested strategies to protect your portfolio. Read More
Terrorist attacks on merchant shipping in the Red Sea pose a threat to the economy and financial markets that investors are underestimating. Read More
The DEA's reclassification of marijuana would substantially enhance the profitability and social acceptance of weed companies. Read More
Investors are worried about inflation and Fed policy but encouraged by corporate profits. Here’s how to make sense of the market’s volatility. Read More
Our editorial director answers inquiries on cyber crime, portfolio protection, valuation tools, bad consumer deals, solar power, and more. Read More
Net profit margins are a crucial metric for assessing the resilience of businesses. On that score, the news is auspicious. Read More
According to news reports this week, the DEA intends to reevaluate restrictions on marijuana, recognizing its medical benefits. Read More
Federal Reserve officials left interest rates unchanged, amid still elevated inflation and concerns about wage and jobs growth. Read More
Contrary to the warnings of gloomsters, the technology sector is not a bubble that’s about to burst. Read More